GILEAD SCIENCES INC's ticker is and the CUSIP is 375558953. A total of 10 filers reported holding GILEAD SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,232,902 | +55.0% | 243,300 | +59.4% | 0.00% | +100.0% |
| Q2 2023 | $11,760,882 | -64.9% | 152,600 | -62.2% | 0.00% | -75.0% |
| Q1 2023 | $33,478,000 | +57348.3% | 403,500 | -40.6% | 0.00% | -50.0% |
| Q4 2022 | $58,275 | -99.8% | 678,800 | +10.1% | 0.01% | +60.0% |
| Q3 2022 | $38,020,000 | +39.2% | 616,300 | +39.4% | 0.01% | +25.0% |
| Q2 2022 | $27,320,000 | +80.9% | 442,000 | +74.0% | 0.00% | +100.0% |
| Q1 2022 | $15,100,000 | -67.8% | 254,000 | -60.7% | 0.00% | -60.0% |
| Q4 2021 | $46,899,000 | -44.2% | 645,900 | -46.4% | 0.01% | -50.0% |
| Q3 2021 | $84,120,000 | +534.3% | 1,204,300 | +525.3% | 0.01% | +400.0% |
| Q2 2021 | $13,262,000 | +2.4% | 192,600 | -3.9% | 0.00% | 0.0% |
| Q1 2021 | $12,952,000 | -66.8% | 200,400 | -70.1% | 0.00% | -66.7% |
| Q4 2020 | $39,046,000 | -2.9% | 670,200 | +3.5% | 0.01% | -14.3% |
| Q3 2020 | $40,210,000 | -2.3% | 647,500 | +21.0% | 0.01% | -12.5% |
| Q2 2020 | $41,163,000 | -12.2% | 535,000 | -14.7% | 0.01% | -27.3% |
| Q1 2020 | $46,897,000 | -9.2% | 627,300 | -21.1% | 0.01% | +10.0% |
| Q4 2019 | $51,666,000 | +41.0% | 795,100 | +37.6% | 0.01% | +42.9% |
| Q3 2019 | $36,634,000 | +107.7% | 578,000 | +119.8% | 0.01% | +133.3% |
| Q2 2019 | $17,642,000 | -40.2% | 263,000 | -42.0% | 0.00% | -50.0% |
| Q1 2019 | $29,489,000 | -2.1% | 453,600 | -5.8% | 0.01% | -14.3% |
| Q4 2018 | $30,118,000 | -23.8% | 481,500 | -5.9% | 0.01% | -12.5% |
| Q3 2018 | $39,524,000 | +21.4% | 511,900 | +11.4% | 0.01% | +14.3% |
| Q2 2018 | $32,544,000 | +38.4% | 459,400 | +47.2% | 0.01% | +40.0% |
| Q1 2018 | $23,522,000 | -63.3% | 312,000 | -65.1% | 0.01% | -61.5% |
| Q4 2017 | $64,060,000 | +21.4% | 894,200 | +37.1% | 0.01% | +8.3% |
| Q3 2017 | $52,753,000 | -1.9% | 652,000 | -14.2% | 0.01% | 0.0% |
| Q2 2017 | $53,793,000 | +40.6% | 760,000 | +34.9% | 0.01% | +33.3% |
| Q1 2017 | $38,266,000 | -11.0% | 563,400 | -6.2% | 0.01% | -10.0% |
| Q4 2016 | $43,002,000 | +124.8% | 600,500 | +148.4% | 0.01% | +100.0% |
| Q3 2016 | $19,127,000 | +62.5% | 241,750 | +71.4% | 0.01% | +66.7% |
| Q2 2016 | $11,768,000 | +50.7% | 141,065 | +66.0% | 0.00% | +50.0% |
| Q1 2016 | $7,808,000 | -93.8% | 85,000 | -93.1% | 0.00% | -93.5% |
| Q4 2015 | $125,122,000 | +12.7% | 1,236,500 | +9.4% | 0.03% | +3.3% |
| Q3 2015 | $111,004,000 | – | 1,130,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Markets Trading UK LLP | 185,000 | $13,124,000 | 0.18% |
| GROUP ONE TRADING, L.P. | 876,400 | $61,217,000 | 0.07% |
| SIMPLEX TRADING, LLC | 679,600 | $46,980,000 | 0.04% |
| Maven Securities LTD | 12,200 | $852,000 | 0.03% |
| SG Americas Securities, LLC | 605,000 | $4,870,000 | 0.02% |
| Marathon Trading Investment Management LLC | 4,000 | $279,000 | 0.02% |
| JPMORGAN CHASE & CO | 1,204,300 | $84,120,000 | 0.01% |
| Allianz Asset Management GmbH | 102,400 | $7,153,000 | 0.01% |
| HRT FINANCIAL LP | 14,100 | $984,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |